We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen, Sanofi Ink Pay-for-Performance Deal With Cigna for Cholesterol Drugs
Amgen, Sanofi Ink Pay-for-Performance Deal With Cigna for Cholesterol Drugs
Amgen and Sanofi are the latest companies to climb on the pay-for-performance bandwagon after reaching agreements with insurer Cigna for their respective cholesterol drugs, Repatha and Praluent.